Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to participate in trial for innovative mapping and pulsed field ablation system

Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center became the first facility in the U.S. to join a clinical trial evaluating the safety and effectiveness of a next-generation mapping and pulsed intervention approach for arrhythmia care. The release provides no efficacy results or performance metrics yet, so the immediate market implications appear limited.